| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/29/2012 | US8187826 Quantitative analysis of in vivo mutation at the Pig-A locus |
| 05/29/2012 | US8187573 In vivo detection of apoptosis |
| 05/29/2012 | US8187572 Diabetogenic rat model |
| 05/29/2012 | CA2512487C Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 05/29/2012 | CA2403327C Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 05/24/2012 | WO2012068476A2 Poly(vinyl benzoate) nanoparticles for molecular delivery |
| 05/24/2012 | WO2012021800A3 Caspase inhibitors as therapeutics for neural and organ injury and imaging |
| 05/24/2012 | US20120128596 Fluorescent phospholipid ether compounds, compositions, and methods of use |
| 05/24/2012 | US20120128595 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| 05/24/2012 | US20120128594 Selective infarcted-tissue-targeting bacteria and use thereof |
| 05/24/2012 | US20120128593 Use of a magnetic resonance imaging medium comprising hyperpolarized 13c pyruvate for the detection of inflammation or infection |
| 05/24/2012 | US20120128592 Surface enhanced raman spectroscopy (sers) compounds and methods of their preparation |
| 05/24/2012 | US20120128591 Anti-fap antibodies and methods of use |
| 05/24/2012 | US20120128590 Nanoparticle delivery systems for membrane-integrating peptides |
| 05/24/2012 | US20120128589 Perfluoro Compounds For Use In Imaging |
| 05/24/2012 | US20120128586 Method for treating chronic lymphocytic leukemia |
| 05/24/2012 | US20120128585 Method of Diagnosing the presence of a tumor in a mammal by assessing CDO expression level |
| 05/24/2012 | US20120128583 Dtpa derivative, metal complex, mr and ct contrast agent and method for manufacturing same |
| 05/24/2012 | US20120128581 Sincalide Formulations |
| 05/23/2012 | EP2455105A2 Bombesin analogues |
| 05/23/2012 | EP2454271A2 Peptides whose uptake in cells is controllable |
| 05/23/2012 | EP2453926A2 Peptides whose uptake in cells is controllable |
| 05/23/2012 | EP2453923A2 Peptide-mediated non-covalent delivery of active agents across the blood brain barrier |
| 05/23/2012 | EP1660884B1 Crown ether derivatives |
| 05/23/2012 | CN102470181A ε-聚赖氨酸缀合物及其用途 ε- polylysine conjugates and their use |
| 05/23/2012 | CN102470100A 用于制备并入了有效生物活性分子的微粒的方法 For the preparation of biologically active molecules incorporated into the microparticles effective method |
| 05/23/2012 | CN102469951A 用于影响和/或探测磁性粒子的装置和方法 Apparatus and method for impact and / or for the detection of magnetic particles |
| 05/23/2012 | CN102465117A Chimeric simian/human immunodeficency virus strain and application thereof |
| 05/23/2012 | CN102464874A 星型多臂plga/peg两亲性嵌段共聚物及其应用 Star Dobby plga / peg amphiphilic block copolymer and its application |
| 05/23/2012 | CN102464690A 2'，3'-二脱氧-2'-[氟-18]氟腺苷化合物及其制备方法 2 ', 3'-dideoxy-2' - [18F] fluoro-adenosine compounds and methods |
| 05/23/2012 | CN102462847A 新型肿瘤靶向造影剂 The new tumor targeting contrast agent |
| 05/23/2012 | CN102068707B Traditional Chinese medicine contrast medium adjuvant used for B ultrasonic and preparation method thereof |
| 05/23/2012 | CN101890173B Preparation method of magnetic resonance imaging contrast agent of magnetic water-soluble chitosan |
| 05/23/2012 | CN101843907B Preparation method of SPIO.SiO2-WGA (Wheat Germ Agglutinin) intestinal wall targeting contrast agent |
| 05/23/2012 | CN101812092B Manganese compound and preparation method and application thereof |
| 05/23/2012 | CN101670095B Pharmaceutical composition for treating embolism and preparation method thereof |
| 05/22/2012 | US8182790 Contrast agents |
| 05/22/2012 | CA2374964C Process for producing an injectable medicament preparation |
| 05/18/2012 | WO2012065045A2 Development and screening of contrast agents for in vivo imagining of parkinson's disease |
| 05/18/2012 | WO2012063955A1 Therapeutic agent for arteriosclerosis or arteriosclerotic disorders and diagnostic agent for arteriosclerosis or arteriosclerotic disorders |
| 05/18/2012 | WO2012063186A1 Colon screening by using magnetic particle imaging |
| 05/18/2012 | WO2012062949A1 Liposomes with antibodies against markers of the cerebral peri-infarct zone |
| 05/17/2012 | US20120124681 Dna fragment and pharmaceutical composition |
| 05/17/2012 | US20120121606 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
| 05/17/2012 | US20120121601 Mammalian receptor proteins; related reagents and methods |
| 05/17/2012 | US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/17/2012 | US20120121518 Multifunctional imaging and therapeutic nanoparticles |
| 05/17/2012 | US20120121517 Biodegradable and thermosensitive poly(organophosphazene)-superparamagnetic nanoparticle complex, preparation method and use thereof |
| 05/17/2012 | US20120121516 Emulsion Activatable by Ultrasounds and Method for Producing Same |
| 05/17/2012 | US20120121515 Methods and compositions for cell-proliferation-related disorders |
| 05/17/2012 | US20120121514 Needle array assembly and method for delivering therapeutic agents |
| 05/17/2012 | US20120121513 Platform technologies for spontaneously occurring diseases |
| 05/17/2012 | US20120121512 Monoclonal antibodies and their use |
| 05/17/2012 | US20120121511 Infection detection methods and systems and related compounds and compositions |
| 05/17/2012 | US20120121510 Localized therapy following breast cancer surgery |
| 05/17/2012 | US20120121509 Vital fluorochrome conjugates and methods of use |
| 05/17/2012 | US20120121507 Peptide ligands for clusterin and uses thereof |
| 05/17/2012 | US20120121505 Therapeutic compositions and methods |
| 05/17/2012 | US20120121504 B cell surface reactive antibodies |
| 05/17/2012 | US20120121501 Hmgn2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 05/16/2012 | EP2452622A1 Colon screening by using magnetic particle imaging |
| 05/16/2012 | EP2451776A2 N-alkoxyamide conjugates as imaging agents |
| 05/16/2012 | EP2451488A2 Multimodal visible polymer embolization material |
| 05/16/2012 | EP2451487A1 In vivi tumor vasculature imaging |
| 05/16/2012 | EP1904460B1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 05/16/2012 | CN1932513B Receiver plate with multiple cross-sections |
| 05/16/2012 | CN102458481A 用于诊断和预测疾病的含三甲胺的化合物 Compounds for the diagnosis and prediction of disease containing trimethylamine |
| 05/16/2012 | CN102451475A Ultrasonic couplant, supporting astringent and preparation methods thereof |
| 05/15/2012 | US8178315 Uniformly distributing a known amount of radioactive isotope 99mTc sulphur colloid and a cyanobacteria of spirulina throughout eggs; lyophilizing the markers and the edible food; gastric emptying test meals |
| 05/15/2012 | US8178077 Drug development target protein and target gene, and method of screening |
| 05/15/2012 | US8178076 Diagnosis and assessment of skeletal related disease using calcium 41 |
| 05/10/2012 | WO2012061113A2 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis |
| 05/10/2012 | WO2012059576A1 Cest systems exhibiting a concentration independent responsiveness |
| 05/10/2012 | WO2012027527A3 Microreactor and method for preparing a radiolabeled complex or a biomolecule conjugate |
| 05/10/2012 | WO2012024634A3 Environmentally-responsive nanocomposites and methods of their use |
| 05/10/2012 | WO2012022919A3 Nalbuphine-based formulations and uses thereof |
| 05/10/2012 | WO2012021046A3 Radial shape of polymer compound containing iodine, preparation method thereof, and ct contrast medium composition containing same |
| 05/10/2012 | US20120117671 Steatohepatitis-liver cancer model animal |
| 05/10/2012 | US20120117667 Novel coelenterazine substrates and methods of use |
| 05/10/2012 | US20120116360 Treatment of neurological disorders |
| 05/10/2012 | US20120114565 Compounds modulators of vegf activity and uses thereof |
| 05/10/2012 | US20120114564 Mri t1 contrasting agent comprising manganese oxide nanoparticle |
| 05/10/2012 | US20120114563 Optical imaging agents |
| 05/10/2012 | US20120114562 Method for treating pervasive development disorders |
| 05/10/2012 | US20120114561 Methods for the treatment of neurodegenerative disorders |
| 05/10/2012 | US20120114560 Abeta binding molecules |
| 05/10/2012 | US20120114559 Nanoimprint lithography formation of functional nanoparticles using dual release layers |
| 05/10/2012 | US20120114558 Aptamer-mediated drug release |
| 05/10/2012 | US20120114555 Method for treating immune disorders |
| 05/10/2012 | DE102010050644A1 Verfahren zur Herstellung von mit Kohlenstoff geschützten superparamagnetischen oder magnetischen Nanosphären A process for the preparation of protected with carbon superparamagnetic or magnetic nanospheres |
| 05/10/2012 | CA2816948A1 Cest systems exhibiting a concentration independent responsiveness |
| 05/10/2012 | CA2816797A1 Microsphere comprising a lanthanide metal complex |
| 05/09/2012 | EP2448574A1 Synthesis and use of fluorophore-tagged antimalarials |
| 05/09/2012 | EP1711052B1 Mouse model for psoriasis and psoriatic arthritis |
| 05/09/2012 | EP1379337B1 Generation of pharmaceutical agent particles using focused acoustic energy |
| 05/09/2012 | CN102441180A Gastrointestinal B-ultrasonic developer |
| 05/09/2012 | CN102441179A Silicon dioxide base ultrasonic contrast medium/high intensity focused ultrasound (HIFU) synergist and preparation method thereof |
| 05/09/2012 | CN102441178A Chinese medicinal development assistant for B-type ultrasonography |
| 05/09/2012 | CN102440961A Targeting polymer micelle containing acid-sensitive subsurface, and preparation method thereof |
| 05/09/2012 | CN101935070B Method for synthesizing superparamagnetic ferroferric oxide nano particle in situ by induction of acrylic acid polymer nano hydrogel |